Feb 6, 2024 | Claims, Cost Savings, Drug costs, Gene therapy, Genetic testing, MedBen Rx, MedBen University, News, Pharmacogenomics, Pharmacy Benefits Manager (PBM), Rx Costs, Specialty Drugs
MedBen recently had the honor to welcome some of the most respected names in the benefits management industry. At the invitation-only 2024 Benefits Advisory Conference on January 26, attending brokers learned about health plan innovations that will help self-funded...
Sep 29, 2023 | Announcements, Biosimilar, Humira, MedBen Rx, News, Perigon Pharmacy 360, Ventegra
Here’s some cost-saving news for MedBen Rx clients who use Ventegra as their processor. On July 1, 2023, biosimilar products were released for the popular and expensive anti-inflammatory therapy, Humira. A 30-day supply of Humira, which is used to treat a variety of...
Jan 6, 2023 | Comparative Effectiveness, Cost Plus Pricing, MedBen Rx, News, Prescription drugs, Rx Costs, Rx prices, Specialty Drugs
From Reuters: “Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA plan to raise prices in the United States on more than 350 unique drugs in early January, according to data analyzed by healthcare research...
